Reconstructed epidermis and full-thickness skin for absorption testing: Influence of the vehicles used on steroid permeation

Alternatives to Laboratory Animals

Volumn 36, Issue 4, 2008, Pages 441-452

  Schäfer Korting, Monika ^a   Mahmoud, Ashraf ^a   Borgia, Simone Lombardi ^a   Brüggener, Barbara ^a   Kleuser, Burkhard ^a   Schreiber, Sylvia ^a   Mehnert, Wolfgang ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Alveolar tissue; Formulation effects; Human skin models; Reconstructed full thickness skin; Reconstructed human epidermis; Skin absorption

Indexed keywords

ALCOHOL; HYDROCORTISONE; MIGLYOL; TESTOSTERONE; WATER OIL CREAM;

ADULT; ANIMAL TISSUE; ARTICLE; ARTIFICIAL MEMBRANE; CONTROLLED STUDY; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; EPIDERMIS; EXPERIMENTAL MODEL; FEMALE; FULL THICKNESS SKIN GRAFT; HUMAN; HUMAN TISSUE; NONHUMAN; PRIORITY JOURNAL; SKIN PERMEABILITY; SWINE;

SUIDAE;

EID: 53949103329     PISSN: 02611929     EISSN: None     Source Type: Journal    
DOI: 10.1177/026119290803600405     Document Type: Article

References (45)

1. Fentem, J., Archer, G., Balls, M., Botham, P., Curren, R., Earl, L., Esdaile, D., Holzhütter, H-G. & Liebsch, M. (1998). The ECVAM international validation study on in vitro tests for skin corrosivity. II: Results and evaluation by the management team. Toxicology in Vitro 12, 483-524.
2. Fentem, J.H. (1999). Validation of in vitro tests for skin corrosivity. ALTEX 16, 150-153.
3. Hoffmann, J., Heisler, E., Karpinski, S., Losse, J., Thomas, D., Siefken, W., Ahr, H.J., Vohr, H.W. & Fuchs, H.W. (2005). Epidermal-skin-test 1,000 (EST-1,000) - a new reconstructed epidermis for in vitro skin corrosivity testing. Toxicology in Vitro 19, 925-929.
4. Kandarova, H., Liebsch, M., Spielmann, H., Genschow, E., Schmidt, E., Traue, D., Guest, R., Whittingham, A., Warren, N., Gamer, A.O., Remmele, M., Kaufmann, T., Wittmer, E., De Wever, B. & Rosdy, M. (2006). Assessment of the human epidermis model SkinEthic RHE for in vitro skin corrosion testing of chemicals according to new OECD TG 431. Toxicology in Vitro 20, 547-559.
5. Liebsch, M., Traue, D., Barrabas, C., Spielmann, H., Uphill, P., Wilkins, S., McPherson, J., Wiemann, C., Kaufmann, T., Remmele, M. & Holzhütter, H-G. (2000). The ECVAM prevalidation study on the use of EpiDerm for skin corrosivity testing. ATLA 28, 371-401.
6. Cotovio, J., Grandidier, M.H., Portes, P., Roguet, R. & Rubinstenn, G. (2005). The in vitro skin irritation of chemicals: optimisation of the EPISKIN prediction model within the framework of the ECVAM validation process. ATLA 33, 329-349.
7. Kandarova, H., Liebsch, M., Genschow, E., Gerner, I., Traue, D., Slawik, B. & Spielmann, H. (2004). Optimisation of the EpiDerm test protocol for the upcoming ECVAM validation study on in vitro skin irritation tests. ALTEX 21, 107-114.
8. Kandarova, H., Liebsch, M., Gerner, I., Schmidt, E., Genschow, E., Traue, D. & Spielmann, H. (2005). The EpiDerm test protocol for the upcoming ECVAM validation study on in vitro skin irritation tests - an assessment of the performance of the optimised test. ATLA 33, 351-367.
9. Spielmann, H., Hoffmann, S., Liebsch, M., Botham, P., Fentem, J.H., Eskes, C., Roguet, R., Cotovio, J., Cole, T., Worth, A., Heylings, J., Jones, P., Robles, C., Kandarova, H., Gamer, A., Remmele, M., Curren, R., Raabe, H., Cockshott, A., Gerner, I. & Zuang, V. (2007). The ECVAM international validation study on in vitro tests for acute skin irritation: report on the validity of the EPISKIN and EpiDerm assays and on the skin integrity function test. ATLA 35, 559-601.
10. Curren, R., Southee, J., Spielmann, H., Liebsch, M., Fentem, J. & Balls, M. (1995). The role of prevalidation in the devlopment, validation and acceptance of alternative methods. ATLA 23, 211-217.
11. Flamand, N., Marrot, L., Belaidi, J.P., Bourouf, L., Dourille, E., Feltes, M. & Meunier, J.R. (2006). Development of genotoxicity test procedures with Episkin, a reconstructed human skin model: towards new tools for in vitro risk assessment of dermally applied compounds? Mutation Research 606, 39-51.
12. Kirkland, D., Pfuhler, S., Tweats, D., Aardema, M., Corvi, R., Darroudi, F., Elhajouji, A., Glatt, H., Hastwell, P., Hayashi, M., Kasper, P., Kirchner, S., Lynch, A., Marzin, D., Maurici, D., Meunier, J.R., Muller, L., Nohynek, G., Parry, J., Parry, E., Thybaud, V., Tice, R., van Benthem, J., Vanparys, P. & White, P. (2007). How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop. Mutation Research 628, 31-55.
13. Aeby, P., Wyss, C., Beck, H., Griem, P., Scheffler, H. & Goebel, C. (2004). Characterization of the sensitizing potential of chemicals by in vitro analysis of dendritic cell activation and skin penetration. Journal of Investigative Dermatology 122, 1154-1164.
14. Basketter, D., Pease, C., Kasting, G., Kimber, I., Casati, S., Cronin, M., Diembeck, W., Gerberick, F., Hadgraft, J., Hartung, T., Marty, J.P., Nikolaidis, E., Patlewicz, G., Roberts, D., Roggen, E., Rovida, C. & van de Sandt, J. (2007). Skin sensitisation and epidermal disposition: the relevance of epidermal disposition for sensitisation hazard identification and risk assessment. The report and recommendations of ECVAM Workshop 59. ATLA 35, 137-154.
15. Jacobs, J.J., Lehe, C.L., Cammans, K.D., Das, P.K. & Elliott, G.R. (2004). Assessment of contact allergens by dissociation of irritant and sensitizing properties. Mutation Research 18, 681-690.
16. OECD (2004). OECD Guideline for the Testing of Chemicals. No. 428. Skin Absorption: In Vitro Method. Original Guideline, adopted 13th April 2004, 8pp. Paris, France: OECD.
17. OECD (2003). Guidance Document for the Conduct of Skin Absorption Studies. OECD Series on Testing and Assessment No. 28. Adopted at the 35th Joint Meeting, August 2003, 31pp. Paris, France: OECD.
18. Lundehn, J-R., Westphal, D., Kieczka, H., Krebs, B., Löcher-Bolz, S., Maasfeld, W. & Pick, E-D. (1992). Uniform Principles for Safeguarding the Health of Applicators of Plant Protection Products (Uniform Principles for Operator Protection). Mitteilungen aus der Biologischen Bundesanstalt für Land- und Forstwirtschaft, No. 277, 112pp. Berlin, Germany: Paul Parey. Available at: http://www.bba.de/veroeff/mitt/mittvertrieb.htm (Accessed 28.08.08).
19. van Ravenzwaay, B. & Leibold, E. (2004). The significance of in vitro rat skin absorption studies to human risk assessment. Toxicology in Vitro 18, 219-225.
20. Haberland, A., Schreiber, S., Maia, C.S., Rübbelke, M.K., Schaller, M., Korting, H.C., Kleuser, B., Schimke, I. & Schäfer-Korting, M. (2006). The impact of skin viability on drug metabolism and permeation - BSA toxicity on primary keratinocytes. Toxicology in Vitro 20, 347-354.
21. Schäfer-Korting, M., Bock, U., Gamer, A., Haberland, A., Haltner-Ukomadu, E., Kaca, M., Kamp, H., Kietzmann, M., Korting, H.C., Krächter, H.U., Lehr, C.M., Liebsch, M., Mehling, A., Netzlaff, F., Niedorf, F., Rübbelke, M.K., Schaefer, U., Schmidt, E., Schreiber, S., Schröder, K.R., Spielmann, H. & Vuia, A. (2006). Reconstructed human epidermis for skin absorption testing: results of the German prevalidation study. ATLA 34, 283-294.
22. Schreiber, S., Mahmoud, A., Vuia, A., Rübbelke, M.K., Schmidt, E., Schaller, M., Kandarova, H., Haberland, A., Schaefer, U.F., Bock, U., Korting, H.C., Liebsch, M. & Schäfer-Korting, M. (2005). Reconstructed epidermis versus human and animal skin in skin absorption studies. Toxicology in Vitro 19, 813-822.
23. Dreher, F., Fouchard, F., Patouillet, C., Andrian, M., Simonnet, J.T. & Benech-Kieffer, F. (2002). Comparison of cutaneous bioavailability of cosmetic preparations containing caffeine or alpha-tocopherol applied on human skin models or human skin ex vivo at finite doses. Skin Pharmacology & Applied Skin Physiology 15 Suppl. 1, 40-58.
24. Lombardi Borgia, S., Schlupp, P., Mehnert, W. & Schäfer-Korting, M. (2008). In vitro skin absorption and drug release - A comparison of six commercial prednicarbate preparations for topical use. European Journal of Pharmaceutics & Biopharmaceutics 68, 380-389.
25. Wagner, H., Kostka, K.H., Adelhardt, W. & Schaefer, U.F. (2004). Effects of various vehicles on the penetration of flufenamic acid into human skin. European Journal of Pharmaceutics & Biopharmaceutics 58, 121-129.
26. Santos Maia, C., Mehnert, W., Schaller, M., Korting, H., Gysler, A., Haberland, A. & Schäfer-Korting, M. (2002). Drug targeting by solid lipid nanoparticles for dermal use. Journal of Drug Targeting 10, 489-495.
27. Takahashi, K., Sakano, H., Numata, N., Kuroda, S. & Mizuno, N. (2002). Effect of fatty acid diesters on permeation of anti-inflammatory drugs through rat skin. Drug Development & Industrial Pharmacy 28, 1285-1294.
28. Wagner, H., Kostka, K.H., Lehr, C.M. & Schaefer, U.F. (2001). Interrelation of permeation and penetration parameters obtained from in vitro experiments with human skin and skin equivalents. Journal of Controlled Release 75, 283-295.
29. Münster, U., Hammer, S., Blume-Peytavi, U. & Schäfer-Korting, M. (2003). Testosterone metabolism in human skin cells in vitro and its interaction with estradiol and dutasteride. Skin Pharmacology & Applied Skin Physiology 16, 356-366.
30. Lange, K., Kleuser, B., Gysler, A., Bader, M., Maia, C., Scheidereit, C., Korting, H.C. & Schäfer-Korting, M. (2000). Cutaneous inflammation and proliferation in vitro: differential effects and mode of action of topical glucocorticoids. Skin Pharmacology & Applied Skin Physiology 13, 93-103.
31. Nohynek, G.J., Duche, D., Garrigues, A., Meunier, P.A., Toutain, H. & Leclaire, J. (2005). Under the skin: Biotransformation of para-aminophenol and para-phenylenediamine in reconstructed human epidermis and human hepatocytes. Toxicology Letters 158, 196-212.
32. Aghazarian, V., Tchiakpe, L., Reynier, J.P. & Gayte-Sorbier, A. (1999). Release of benzimidazole and benzylidene camphor from topical sunscreen formulations. Drug Development & Industrial Pharmacy 25, 1277-1282.
33. Tas, C., Ozkan, Y., Savaser, A. & Baykara, T. (2004). In vitro and ex vivo permeation studies of chlorpheniramine maleate gels prepared by carbomer derivatives. Drug Development & Industrial Pharmacy 30, 637-647.
34. Niedorf, F., Schmidt, E. & Kietzmann, M. (2008). The automated, accurate and reproducible determination of steady-state permeation parameters from percutaneous permeation data. ATLA 36, 201-213.
35. Higuchi, T. (1961). Rate of release of medicaments from ointment bases containing drags in suspension. Journal of Pharmaceutical Sciences 50, 874-875.
36. Skoug, J.W., Borin, M.T., Fleishaker, J.C. & Cooper, A.M. (1991). In vitro and in vivo evaluation of whole and half tablets of sustained-release adinazolam mesylate. Pharmaceutical Research 8, 1482-1488.
37. Boelsma, E., Gibbs, S., Faller, C. & Ponec, M. (2000). Characterization and comparison of reconstructed skin models: morphological and immunohistochemical evaluation. Acta Dermato-Venereologica 80, 82-88.
38. Ponec, M., Boelsma, E., Weerheim, A., Mulder, A., Bouwstra, J. & Mommaas, M. (2000). Lipid and ultrastructural characterization of reconstructed skin models. International Journal of Pharmaceutics 203, 211-225.
39. Schäfer-Korting, M. & Schreiber, S. (2008). Use of skin equivalences for dermal absorption and toxicity. In Dermal Absorption and Toxicity Assessment 2nd Edition (ed. M.S. Roberts & K.A. Walters), pp. 141-159. New York, NY, USA: Informa Healthcare.
40. Tang, H., Blankschtein, D. & Langer, R. (2002). Prediction of steady-state skin permeabilities of polar and nonpolar permeants across excised pig skin based on measurements of transient diffusion: characterization of hydration effects on the skin porous pathway. Journal of Pharmaceutical Sciences 91, 1891-1907.
41. Cross, S.E., Magnusson, B.M., Winckle, G., Anissimov, Y. & Roberts, M.S. (2003). Determination of the effect of lipophilicity on the in vitro permeability and tissue reservoir characteristics of topically applied solutes in human skin layers. Journal of Investigative Dermatology 120, 759-764.
42. Diembeck, W., Beck, H., Benech-Kieffer, F., Courtellemont, P., Dupuis, J., Lovell, W., Paye, M., Spengler, J. & Steiling, W. (1999). Test guidelines for in vitro assessment of dermal absorption and percutaneous penetration of cosmetic ingredients. European Cosmetic, Toiletry and Perfumery Association. Food & Chemical Toxicology 37, 191-205.
43. Kogan, A. & Garti, N. (2006). Microemulsions as transdermal drug delivery vehicles. Advances in Colloid & Interface Science 123-126, 369-385.
44. Marjukka Suhonen, T., Bouwstra, J.A. & Urtti, A. (1999). Chemical enhancement of percutaneous absorption in relation to stratum corneum structural alterations. Journal of Controlled Release 59, 149-161.
45. Gysler, A., Lange, K., Korting, H.C. & Schäfer-Korting, M. (1997). Prednicarbate biotransformation in human foreskin keratinocytes and fibroblasts. Pharmaceutical Research 14, 793-797.